With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion plans that are aimed, at least in part, at abating the Trump administration ...
Johnson & Johnson on Wednesday announced plans to invest more than $1 billion in a next-generation manufacturing facility that will produce advanced cell therapy technologies. The facility will be ...
Johnson & Johnson JNJ-0.45%decrease; red down pointing triangle will invest more than $1 billion in a next generation cell therapy manufacturing facility in Montgomery County, Pa. The company said the ...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced a more than $1 billion investment in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results